Afternoon trading March 16, page-51

  1. 2,770 Posts.
    BOT waiting for news ---- FDA mid-cycle review process is scheduled for completion in Q1 2023
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.